ClinicalTrials.govpublic full text
A Study to Evaluate Safety and Efficacy of GSK1278863 in Non-Dialysis Dependent (NDD) Subjects With Anemia Associated With Chronic Kidney Diseases (CKD)
anaemia, prolyl hydroxylase inhibitor, pharmacokinetics, gsk1278863, anemia, hemoglobin, erythropoiesis stimulating agents, chronic kidney disease, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 872918
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.